BioLight Life Sciences Ltd. (BOLT.TA)

ILA 642.0

(0.0%)

Operating Income Summary of BioLight Life Sciences Ltd.

BioLight Life Sciences Ltd.'s latest annual operating income in 2023 was -26.56 Million ILS , down -205.5% from previous year.
BioLight Life Sciences Ltd.'s latest quarterly operating income in 2024 Q2 was 468 Thousand ILS , down 0.0% from previous quarter.
BioLight Life Sciences Ltd. reported an annual operating income of -8.69 Million ILS in 2022, down -1534.77% from previous year.
BioLight Life Sciences Ltd. reported an annual operating income of -532 Thousand ILS in 2021, up 95.3% from previous year.
BioLight Life Sciences Ltd. reported a quarterly operating income of -5.88 Million ILS for 2023 Q2, down 0.0% from previous quarter.
BioLight Life Sciences Ltd. reported a quarterly operating income of -6.99 Million ILS for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of BioLight Life Sciences Ltd. (2023 - 2012)

Historical Annual Operating Income of BioLight Life Sciences Ltd. (2023 - 2012)

Year	Operating Income	Operating Income Growth
2023	-26.56 Million ILS	-205.5%
2022	-8.69 Million ILS	-1534.77%
2021	-532 Thousand ILS	95.3%
2020	-11.32 Million ILS	19.19%
2019	-14.01 Million ILS	-125.98%
2018	53.95 Million ILS	300.73%
2017	-26.87 Million ILS	11.59%
2016	-30.4 Million ILS	-14.48%
2015	-26.55 Million ILS	20.98%
2014	-33.6 Million ILS	-18.16%
2013	-28.44 Million ILS	1.4%
2012	-28.84 Million ILS	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	468 Thousand ILS	0.0%
2023 Q2	-5.88 Million ILS	0.0%
2023 Q4	-6.99 Million ILS	0.0%
2023 FY	-10.65 Million ILS	-22.47%
2022 Q4	-5.29 Million ILS	0.0%
2022 FY	-8.69 Million ILS	-1534.77%
2022 Q2	-5.02 Million ILS	0.0%
2021 Q4	-5.09 Million ILS	0.0%
2021 Q2	-5.51 Million ILS	0.0%
2021 FY	-532 Thousand ILS	95.3%
2020 FY	-11.32 Million ILS	19.19%
2020 Q4	-2.51 Million ILS	-44.24%
2020 Q3	-1.74 Million ILS	44.39%
2020 Q2	-3.13 Million ILS	20.11%
2020 Q1	-3.92 Million ILS	-20.05%
2019 Q4	-3.27 Million ILS	22.46%
2019 Q1	-4.01 Million ILS	29.5%
2019 Q2	-2.51 Million ILS	37.46%
2019 Q3	-4.22 Million ILS	-68.06%
2019 FY	-14.01 Million ILS	-125.98%
2018 Q3	70.47 Million ILS	1143.16%
2018 Q1	5.15 Million ILS	188.34%
2018 Q2	5.66 Million ILS	9.91%
2018 FY	53.95 Million ILS	300.73%
2018 Q4	-5.69 Million ILS	-108.08%
2017 Q2	-7.13 Million ILS	-14.1%
2017 Q4	-5.83 Million ILS	23.64%
2017 Q3	-7.64 Million ILS	-7.15%
2017 FY	-26.87 Million ILS	11.59%
2017 Q1	-6.25 Million ILS	36.52%
2016 Q4	-9.85 Million ILS	-89.35%
2016 Q3	-5.2 Million ILS	9.78%
2016 FY	-30.4 Million ILS	-14.48%
2016 Q2	-5.76 Million ILS	39.77%
2016 Q1	-9.57 Million ILS	-51.35%
2015 Q1	-6.16 Million ILS	23.56%
2015 Q4	-6.32 Million ILS	-4.1%
2015 Q3	-6.07 Million ILS	23.87%
2015 Q2	-7.98 Million ILS	-29.44%
2015 FY	-26.55 Million ILS	20.98%
2014 Q3	-7.55 Million ILS	27.75%
2014 Q2	-10.45 Million ILS	0.0%
2014 FY	-33.6 Million ILS	-18.16%
2014 Q4	-8.06 Million ILS	-6.85%
2013 FY	-28.44 Million ILS	1.4%
2013 Q4	-14.55 Million ILS	0.0%
2013 Q2	-13.89 Million ILS	0.0%
2012 FY	-28.84 Million ILS	0.0%

Peer Operating Income Comparison of BioLight Life Sciences Ltd.

Name	Operating Income	Operating Income Difference
Matricelf Ltd	-12.59 Million ILA	-110.932%